Quantcast

Latest TARRYTOWN Stories

2014-09-22 04:21:43

TARRYTOWN, N.Y., Sept. 22, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for EYLEA(®) (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV). EYLEA has already been approved in Japan for the treatment of patients with neovascular age-related macular degeneration (wet AMD), and...

2014-09-16 23:07:17

“Festive Evening of Song” to take place Monday, September 29 at the Tappan Hill Mansion NEW YORK (PRWEB) September 16, 2014 Today The FSH Society, a world leader in combating muscular dystrophy, announced that its annual “Festive Evening of Song,” featuring luminary pianist Steven Blier and two-time Grammy Award winner Sylvia McNair, will take place on Monday, September 29, 2014 at the Tappan Hill Mansion, located on the former Mark Twain estate in Tarrytown, New York. The FSH...

2014-07-29 20:23:16

DME is the third approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA(®) (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The recommended dosage of EYLEA in patients with DME is 2 milligrams (mg) every two months (8 weeks) after five initial monthly injections. Although EYLEA may be dosed as...

2014-07-18 08:23:16

TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that in the Phase 3 VIVID-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser...

2014-06-04 08:29:41

MONTCLAIR, N.J., June 4, 2014 /PRNewswire/ -- There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can frontline practitioners do to meet the challenges of this growing public health issue? Attend PAINWeekEnd in Tarrytown, convenient to New York, New Jersey, and Connecticut practitioners! The 2014 PAINWeekEnd Regional Conference convenes on Saturday, June...

2014-04-03 16:24:08

Fellowship Program in Collaboration with NASA, Teachers College, Columbia University and STEM Education Leadership Center TARRYTOWN, N.Y., April 3, 2014 /PRNewswire/ -- In a new initiative to promote STEM (Science Technology Engineering Math) education in New York's Hudson Valley, Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced a collaboration with NASA, Teachers College, Columbia University and the STEM Education Leadership Center of Rye, New York to create the Hudson...

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2013-11-26 23:20:48

The clinical benefits of using hyperbaric oxygen therapy for breast cancer patients undergoing breast reconstruction has been described in a poster presentation at the 28th Annual Clinical Symposium on Advances in Skin & Wound Care held on October 23-27 at Lake Buena Vista, FL. In threatened mastectomy skin flaps treated at Good Samaritan Hospital, Suffern, NY, over a 4 year, 15 patient period, an 87.5% success rate was realized when hyperbaric oxygen therapy was used, against a...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related